CHICAGO TRUST Co NA cut its holdings in shares of Eli Lilly and Company (NYSE:LLY) by 1.9% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,540 shares of the company’s stock after selling 67 shares during the quarter. CHICAGO TRUST Co NA’s holdings in Eli Lilly and were worth $291,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the business. Vanguard Group Inc. increased its holdings in Eli Lilly and by 3.3% during the 1st quarter. Vanguard Group Inc. now owns 68,597,006 shares of the company’s stock worth $5,769,694,000 after purchasing an additional 2,181,701 shares during the last quarter. BlackRock Inc. increased its holdings in Eli Lilly and by 2,628.5% during the 1st quarter. BlackRock Inc. now owns 62,260,488 shares of the company’s stock worth $5,236,731,000 after purchasing an additional 59,978,664 shares during the last quarter. State Street Corp increased its holdings in Eli Lilly and by 1.6% during the 1st quarter. State Street Corp now owns 42,363,935 shares of the company’s stock worth $3,563,230,000 after purchasing an additional 651,424 shares during the last quarter. Geode Capital Management LLC increased its holdings in Eli Lilly and by 8.4% during the 1st quarter. Geode Capital Management LLC now owns 9,103,975 shares of the company’s stock worth $764,597,000 after purchasing an additional 708,597 shares during the last quarter. Finally, Janus Capital Management LLC increased its holdings in shares of Eli Lilly and by 2.8% in the 1st quarter. Janus Capital Management LLC now owns 8,723,692 shares of the company’s stock valued at $733,731,000 after acquiring an additional 237,619 shares during the last quarter. Institutional investors own 75.72% of the company’s stock.

Shares of Eli Lilly and Company (LLY) traded up 0.70% on Friday, reaching $83.91. The company’s stock had a trading volume of 3,148,723 shares. The stock has a 50-day moving average of $80.84 and a 200 day moving average of $82.02. Eli Lilly and Company has a 52 week low of $64.18 and a 52 week high of $86.72. The stock has a market capitalization of $88.53 billion, a price-to-earnings ratio of 36.31 and a beta of 0.34.

Eli Lilly and (NYSE:LLY) last released its quarterly earnings results on Tuesday, July 25th. The company reported $1.11 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.05 by $0.06. Eli Lilly and had a return on equity of 28.71% and a net margin of 11.12%. The firm had revenue of $5.82 billion during the quarter, compared to analysts’ expectations of $5.60 billion. During the same period last year, the firm posted $0.86 EPS. The business’s revenue was up 7.8% on a year-over-year basis. On average, analysts expect that Eli Lilly and Company will post $4.16 EPS for the current year.

A number of brokerages have recently weighed in on LLY. Berenberg Bank reiterated a “buy” rating and issued a $98.00 price target on shares of Eli Lilly and in a report on Friday, August 4th. TheStreet downgraded Eli Lilly and from a “b+” rating to a “c” rating in a report on Wednesday, May 31st. BMO Capital Markets reiterated an “underperform” rating and issued a $73.00 price target on shares of Eli Lilly and in a report on Wednesday, July 26th. Oppenheimer Holdings, Inc. downgraded Eli Lilly and from an “outperform” rating to a “market perform” rating and set a $90.00 price target for the company. in a report on Wednesday, July 26th. Finally, Jefferies Group LLC reiterated a “buy” rating on shares of Eli Lilly and in a report on Tuesday, May 30th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and twelve have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $88.27.

TRADEMARK VIOLATION NOTICE: “CHICAGO TRUST Co NA Has $291,000 Holdings in Eli Lilly and Company (LLY)” was first reported by Watch List News and is the property of of Watch List News. If you are accessing this piece on another site, it was stolen and republished in violation of U.S. & international trademark and copyright law. The legal version of this piece can be viewed at https://www.watchlistnews.com/chicago-trust-co-na-has-291000-holdings-in-eli-lilly-and-company-lly/1583295.html.

In related news, major shareholder Lilly Endowment Inc sold 180,000 shares of the firm’s stock in a transaction on Thursday, August 31st. The stock was sold at an average price of $81.06, for a total transaction of $14,590,800.00. Following the completion of the sale, the insider now directly owns 123,865,804 shares of the company’s stock, valued at approximately $10,040,562,072.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders have sold a total of 590,000 shares of company stock valued at $48,551,300 over the last ninety days. Insiders own 0.20% of the company’s stock.

Eli Lilly and Company Profile

Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company’s human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists.

Want to see what other hedge funds are holding LLY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eli Lilly and Company (NYSE:LLY).

Institutional Ownership by Quarter for Eli Lilly and (NYSE:LLY)

Receive News & Ratings for Eli Lilly and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eli Lilly and Company and related companies with Analyst Ratings Network's FREE daily email newsletter.